Literature DB >> 7952379

Nebulized frusemide for dyspnoea.

P Stone, A Kurowska, A Tookman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7952379     DOI： 10.1177/026921639400800315

Source DB:  PubMed          Journal:  Palliat Med        ISSN： 0269-2163            Impact factor:   4.762


× No keyword cloud information.
  4 in total

Review 1.  Management of lung cancer.

Authors:  A Melville; A Eastwood
Journal:  Qual Health Care       Date:  1998-09

Review 2.  Dyspnea review for the palliative care professional: treatment goals and therapeutic options.

Authors:  Arif H Kamal; Jennifer M Maguire; Jane L Wheeler; David C Currow; Amy P Abernethy
Journal:  J Palliat Med       Date:  2012-01       Impact factor: 2.947

3.  The Effect of Aerosol Saline on Laboratory-Induced Dyspnea.

Authors:  C R O'Donnell; R W Lansing; R M Schwartzstein; Robert Banzett
Journal:  Lung       Date:  2016-12-21       Impact factor: 2.584

4.  An online survey of Australian physicians reported practice with the off-label use of nebulised frusemide.

Authors:  Phillip J Newton; Patricia M Davidson; Christine Sanderson
Journal:  BMC Palliat Care       Date:  2012-04-30       Impact factor: 3.234
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.